课题基金 / 基金详情

项目摘要

项目成果

NANCY SPECK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Summary The goal of this proposal is to understand how hematopoietic stem cells (HSCs) form in the embryo. All HSCs in the adult bone marrow are descendants of pre-hematopoietic stem cells (pre- HSCs) that differentiate from hemogenic endothelial (HE) cells in the major caudal arteries of the embryo. However, only a subset of hematopoietic cells that differentiate from HE cells in the arteries are pre-HSCs, while many are committed lympho-myeloid biased progenitors. We generated a comprehensive single cell dataset that captures the entire developmental trajectory from arterial endothelial cells to lympho-myeloid biased progenitors and pre-HSCs. This dataset is a powerful tool for generating and testing novel concepts in HSC ontogeny. One discovery from this analysis is an endothelial cell precursor of HE cells that we named pre-HE. Pre-HE cells are a transitional population from which a limited number of cells will be specified as HE. We discovered that the efficiency at which pre-HE cells differentiate into HE cells is determined by the levels of RUNX1, a transcription factor that is expressed in HE cells and is essential for HE cell specification. We also identified a candidate enhancer in the Runx1 gene that first becomes accessible in pre-HE cells. One goal of this proposal is to determine if the Runx1 pre-HE enhancer is required for the differentiation of pre-HE cells into HE cells, and which transcription factors and upstream signaling pathways regulate the activity of this enhancer. A second important finding is that we defined the molecular differences between lympho-myeloid biased progenitors and pre- HSCs, and identified genes specifically expressed in each of these populations. One of these genes, Mecom, which is known to regulate adult HSC proliferation and function, is more highly expressed in pre-HSCs than in lympho-myeloid biased progenitors. We will determine if the expression of Mecom in endothelial cells regulates the number of pre-HSCs that are generated during hematopoietic ontogeny. Understanding how arterial HE cells are specified and specialized will help guide ongoing efforts to generate HSCs from other cell sources.
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/nature22326
发表时间: 2017-05-25
期刊: Nature
影响因子: 64.8
作者: [Lis R, Karrasch CC, Poulos MG, Kunar B, Redmond D, Duran JGB, Badwe CR, Schachterle W, Ginsberg M, Xiang J, Tabrizi AR, Shido K, Rosenwaks Z, Elemento O, Speck NA, Butler JM, Scandura JM, Rafii S]
通讯作者: Rafii S
RUNX1 and the endothelial origin of blood.
runx1和血液的内皮起源。
DOI: 10.1016/j.exphem.2018.10.009
发表时间: 2018-12
期刊: Experimental hematology
影响因子: 2.6
作者: [Gao L, Tober J, Gao P, Chen C, Tan K, Speck NA]
通讯作者: Speck NA
DOI: 10.1016/j.immuni.2019.05.017
发表时间: 2019-06-18
期刊: Immunity
影响因子: 32.4
作者: [Bennett L, Mumau M, Speck NA]
通讯作者: Speck NA
DOI: 10.1101/gad.253302.114
发表时间: 2014-12-01
期刊: Genes & development
影响因子: 10.5
作者: [Li Y, Esain V, Teng L, Xu J, Kwan W, Frost IM, Yzaguirre AD, Cai X, Cortes M, Maijenburg MW, Tober J, Dzierzak E, Orkin SH, Tan K, North TE, Speck NA]
通讯作者: Speck NA
23
    Repressing TGFbeta family signaling to promote hematopoietic stem cell formation in the embryo
    • 批准号:
      10589924
    • 项目类别:
    • 资助金额:
      $34.32万
    • 财政年份:
      2022
    • 负责人:
      NANCY SPECK
    • 依托单位:
    Mechanisms of endothelial-to-hemogenic transition mediated by Runx1
    • 批准号:
      9922673
    • 项目类别:
    • 资助金额:
      $38.08万
    • 财政年份:
      2017
    • 负责人:
      NANCY SPECK
    • 依托单位:
    CD27:CD70 signaling in hematopoietic stem cell formation
    • 批准号:
      9374787
    • 项目类别:
    • 资助金额:
      $20.78万
    • 财政年份:
      2017
    • 负责人:
      NANCY SPECK
    • 依托单位:
    Mechanisms of endothelial-to-hemogenic transition mediated by Runx1
    • 批准号:
      9547467
    • 项目类别:
    • 资助金额:
      $47.17万
    • 财政年份:
      2017
    • 负责人:
      NANCY SPECK
    • 依托单位:
    海外基金